Ikena Oncology, Inc.·4

Jan 25, 9:34 PM ET

Wooster Richard 4

4 · Ikena Oncology, Inc. · Filed Jan 25, 2022

Insider Transaction Report

Form 4
Period: 2022-01-21
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-21+29,20029,200 total
    Exercise: $11.06Exp: 2032-01-21Common Stock (29,200 underlying)
Footnotes (1)
  • [F1]This option will vest in equal installments on the first, second, and third anniversaries of the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION